SCHEMBL24028775

SCHEMBL24028775

c1ccc(-c2nc(-c3ccc4ccccc4c3)nc(-c3cc4ccc5ccccc5c4c4sc5ccccc5c34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ TP53 P04637 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ NQO1 P15559 1/20 0.34
▸ NQO2 P16083 1/20 0.34
▸ S1PR5 Q9H228 7/20 0.34
▸ S1PR4 O95977 6/20 0.34
▸ AURKA O14965 1/20 0.32
▸ AURKB Q96GD4 1/20 0.32
▸ MAPT P10636 2/20 0.32
▸ GPR84 Q9NQS5 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ CYP1A1 P04798 2/20 0.32
▸ CYP1B1 Q16678 2/20 0.32
▸ NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24029132 0.99 KDM4E (0.36) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL24029135 0.97 KDM4E (0.36) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL24029008 0.97 LIMK1 (0.34) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL24028764 0.96 NQO2 (0.36) KDM4EALDH1A1SMN1; SMN2CYP1A2NQO1
SCHEMBL24029004 0.95 LIMK1 (0.33) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL24028942 0.95 KDM4E (0.37) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL24028544 0.95 NQO2 (0.34) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL24028951 0.94 KDM4E (0.34) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL24029010 0.94 NQO2 (0.36) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL24029159 0.94 NQO2 (0.36) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230130802-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-04-27 — — US disclosed
WO-2021230654-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-11-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230130802-A1 ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, ELAVL1, EML4 KDM4E 2014/4885MEN1 1824/4885KMT2A 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback